HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Function, therapeutic potential and cell biology of BACE proteases: current status and future prospects.

Abstract
The β-site APP cleaving enzymes 1 and 2 (BACE1 and BACE2) were initially identified as transmembrane aspartyl proteases cleaving the amyloid precursor protein (APP). BACE1 is a major drug target for Alzheimer's disease because BACE1-mediated cleavage of APP is the first step in the generation of the pathogenic amyloidpeptides. BACE1, which is highly expressed in the nervous system, is also required for myelination by cleaving neuregulin 1. Several recent proteomic and in vivo studies using BACE1- and BACE2-deficient mice demonstrate a much wider range of physiological substrates and functions for both proteases within and outside of the nervous system. For BACE1 this includes axon guidance, neurogenesis, muscle spindle formation, and neuronal network functions, whereas BACE2 was shown to be involved in pigmentation and pancreatic β-cell function. This review highlights the recent progress in understanding cell biology, substrates, and functions of BACE proteases and discusses the therapeutic options and potential mechanism-based liabilities, in particular for BACE inhibitors in Alzheimer's disease. The protease BACE1 is a major drug target in Alzheimer disease. Together with its homolog BACE2, both proteases have an increasing number of functions within and outside of the nervous system. This review highlights recent progress in understanding cell biology, substrates, and functions of BACE proteases and discusses the therapeutic options and potential mechanism-based liabilities, in particular for BACE inhibitors in Alzheimer disease.
AuthorsRobert Vassar, Peer-Hendrik Kuhn, Christian Haass, Matthew E Kennedy, Lawrence Rajendran, Philip C Wong, Stefan F Lichtenthaler
JournalJournal of neurochemistry (J Neurochem) Vol. 130 Issue 1 Pg. 4-28 (Jul 2014) ISSN: 1471-4159 [Electronic] England
PMID24646365 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Review)
Copyright© 2014 International Society for Neurochemistry.
Chemical References
  • APP protein, human
  • Amyloid beta-Protein Precursor
  • Amyloid Precursor Protein Secretases
  • Aspartic Acid Endopeptidases
  • BACE1 protein, human
Topics
  • Alzheimer Disease (drug therapy, enzymology)
  • Amyloid Precursor Protein Secretases (antagonists & inhibitors, physiology)
  • Amyloid beta-Protein Precursor (physiology)
  • Animals
  • Aspartic Acid Endopeptidases (antagonists & inhibitors, physiology)
  • Forecasting
  • Humans
  • Intracellular Fluid (drug effects, enzymology)
  • Protein Transport (physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: